Post a Comment Print Share on Facebook
Featured Paradores Turismo Rusia Volodimir Zelenski Pedro Sánchez Real Sociedad

The US will stop financing coronavirus vaccines from 2023 due to lack of funds

MADRID, 31 Ago.

- 10 reads.

The US will stop financing coronavirus vaccines from 2023 due to lack of funds

MADRID, 31 Ago. (EUROPA PRESS) -

The US government will stop funding and providing coronavirus vaccines from January 2023 due to lack of funds, so US citizens will have to pay for them out of pocket if they want to. get immunized

"We have always intended to transition to the commercial market and have been planning for it for some time," said Dawn O'Connell, director of the US Department of Health's Strategic Preparedness and Response Administration.

"Unfortunately, the timeline to make the transition has accelerated over the past six months due to a lack of additional funding from Congress to support this work," he said.

Since the start of the pandemic, the United States government and pharmaceutical companies have gone from discussing the acquisition of vaccines and medicines against the coronavirus to selling them commercially, as is the case with those that immunize against seasonal flu.

O'Connell has reported that the US government will also stop funding other treatments for the disease, such as Pfizer's Paxlovid from mid-2023 as supplies run out. “Funds are urgently needed for next-generation COVID-19 vaccines, therapeutics and tests,” he warned, reports the Bloomberg agency.

The lack of agreement on the part of the United States Congress, to which O'Connell has previously mentioned, has been reflected first in the blocking of some 15,000 million dollars by the Democrats of the House of Representatives in case they came from funds state. Subsequently, it was the Republicans in the Senate who refused to provide $10 billion due to objections to the immigration policies of the Biden Administration.

The United States has purchased 171 million doses of coronavirus vaccines designed to better protect against omicron and other variants. Those booster shots are expected to be licensed for use later this week and offered to people for free. While it might meet current demand, it won't be enough to immunize all adults in the long term.